PubRank

Robert S Klein

Author PubWeight™ 83.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2003 2.81
2 The clonality of Staphylococcus aureus nasal carriage. J Infect Dis 2005 2.39
3 Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy. Clin Infect Dis 2005 2.15
4 Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr 2003 2.11
5 Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 2007 1.95
6 Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis 2001 1.79
7 Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis 2002 1.73
8 Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 2003 1.71
9 Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis 2003 1.70
10 Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis 2002 1.63
11 Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis 2003 1.57
12 The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol 2009 1.56
13 Interpreting the association between HIV and bone mineral density. AIDS 2007 1.43
14 HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis 2011 1.37
15 Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis 2007 1.37
16 Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection. Clin Infect Dis 2002 1.35
17 Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev 2007 1.33
18 High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol 2010 1.31
19 Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer 2006 1.28
20 Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 2003 1.28
21 Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis 2003 1.27
22 Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003 1.24
23 Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STDS 2007 1.22
24 Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. J Acquir Immune Defic Syndr 2004 1.21
25 Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women. J Acquir Immune Defic Syndr 2003 1.20
26 Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women. Am J Epidemiol 2006 1.20
27 The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J Acquir Immune Defic Syndr 2003 1.19
28 Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women. Cancer Epidemiol Biomarkers Prev 2005 1.17
29 Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clin Infect Dis 2002 1.14
30 Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol 2002 1.12
31 Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users. Clin Infect Dis 2003 1.12
32 Prospective study of bone mineral density changes in aging men with or at risk for HIV infection. AIDS 2010 1.06
33 Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis 2004 1.04
34 Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection. Clin Infect Dis 2006 1.02
35 Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging. AIDS 2009 0.99
36 Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999. J Urban Health 2003 0.99
37 Cardiovascular implications of HIV-induced dyslipidemia. Atherosclerosis 2011 0.98
38 Differences between Staphylococcus aureus isolates from medical and nonmedical hospital personnel. J Clin Microbiol 2002 0.98
39 Use of complementary and alternative medicine in inner-city persons with or at risk for HIV infection. AIDS Patient Care STDS 2008 0.95
40 Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003 0.94
41 Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res 2003 0.93
42 The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis 2002 0.93
43 The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans. Hum Immunol 2011 0.93
44 Bacterial vaginosis and the natural history of human papillomavirus. Infect Dis Obstet Gynecol 2011 0.93
45 Incidence and persistence of Staphylococcus aureus nasal colonization in a community sample of HIV-infected and -uninfected drug users. Clin Infect Dis 2007 0.92
46 Effect of HIV infection on atypical squamous cells of undetermined significance. Clin Infect Dis 2006 0.92
47 Vaginal flora morphotypic profiles and assessment of bacterial vaginosis in women at risk for HIV infection. Infect Dis Obstet Gynecol 2005 0.92
48 Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women. J Med Microbiol 2011 0.92
49 The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women. Sex Transm Dis 2011 0.89
50 Relationship of serum immunoglobulin and IgG subclass levels to race, ethnicity and behavioral characteristics in HIV infection. Med Sci Monit 2005 0.88
51 Human leukocyte antigen class I supertypes and HIV-1 control in African Americans. J Virol 2009 0.88
52 Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users. J Acquir Immune Defic Syndr 2006 0.87
53 Hepatitis C virus infection is associated with insulin resistance among older adults with or at risk of HIV infection. AIDS 2007 0.87
54 Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: Risk factors and severity. Obstet Gynecol 2003 0.87
55 Nutritional biomarkers associated with gynecological conditions among US women with or at risk of HIV infection. Am J Clin Nutr 2007 0.85
56 Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression. J Acquir Immune Defic Syndr 2008 0.85
57 Aging and HIV infection. J Urban Health 2006 0.85
58 Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virus. Am J Obstet Gynecol 2003 0.85
59 Association between semen exposure and incident bacterial vaginosis. Infect Dis Obstet Gynecol 2011 0.85
60 Incident hyperglycaemia among older adults with or at-risk for HIV infection. Antivir Ther 2011 0.82
61 Antiangiogenic and antitumor activity of 6-(2-aminoethyl)amino-5-chlorouracil, a novel small-molecule inhibitor of thymidine phosphorylase, in combination with the vascular endothelial growth factor-trap. Clin Cancer Res 2009 0.81
62 Accuracy of clinical diagnosis of bacterial vaginosis by human immunodeficiency virus infection status. Sex Transm Dis 2011 0.81
63 Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users. Med Sci Monit 2006 0.80
64 Abnormal vaginal cytology in HIV-infected and at-risk women after hysterectomy. J Acquir Immune Defic Syndr 2004 0.79
65 Lack of association of herpes simplex virus type 2 seropositivity with the progression of HIV infection in the HERS cohort. Am J Epidemiol 2011 0.78
66 Incidence of and risk factors for genital human papillomavirus infection in women drug users. J Acquir Immune Defic Syndr 2006 0.78
67 The effects of illicit drug use and HIV infection on sex hormone levels in women. Gynecol Endocrinol 2006 0.77
68 Urinary tract infections in women with or at risk for human immunodeficiency virus infection. Am J Obstet Gynecol 2002 0.77
69 Successful initiation of an anal cancer screening and treatment program at a New York City HIV clinic. AIDS 2010 0.76
70 Validity of a self-reported history of a positive tuberculin skin test. A prospective study of drug users. J Gen Intern Med 2004 0.76
71 Chronic liver disease and Streptococcus bovis endocarditis. Clin Infect Dis 2004 0.75
72 Housing insecurity and lack of public assistance are risk factors for tuberculin skin test conversion among persons who use illicit drugs in New York City. J Addict Med 2009 0.75
73 Discussion on frequency of the HIV-protective CC chemokine receptor 5-Delta 32/Delta 32 genotype is increased in hepatitis C. Gastroenterology 2003 0.75
74 Two-step tuberculin skin testing in drug users. J Addict Dis 2007 0.75